BIO Throws its Support for Start-up Jobs and Innovation Act - - BioPharm International

ADVERTISEMENT

BIO Throws its Support for Start-up Jobs and Innovation Act


The Biotechnology Industry Organization (BIO) has expressed its support for the Start-up Jobs and Innovation Act introduced by Senators Robert Menendez (D-NJ) and Pat Toomey (R-PA).  According to BIO, the bill would help small biotech companies by spurring capital for early-stage development of R&D-focused companies. Biotech companies often have a difficult time finding investors because of the long process and cost of bringing a biotech product to market.

“Many research-intensive companies rely on private investment to support their groundbreaking R&D. Because of the long research process intrinsic to scientific advancement, growing innovators operate without product revenue and thus cannot use the sale of one product to finance the development of another. The investment dollars that fund the decade-long, billion-dollar biotech pipeline are supporting the next generation of breakthrough technologies,” says BIO President and CEO James C. Greenwood in a letter to the senators.

“Innovative biotech companies at all stages of the development process are working toward next generation technologies to heal, fuel, and feed the world. [The] Start-up Jobs and Innovation Act will support the early-stage research critical to bringing these breakthroughs to the world,” says Greenwood.

Source: The Biotechnology Industry Organization

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines

Click here